Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma

Rheumatology (Oxford). 2021 Feb 1;60(2):e78. doi: 10.1093/rheumatology/keaa798.

Authors

Alojzija Hočevar^{1

2}, Peter Kopač^{2

3}, Žiga Rotar^{1

2}, Martina Plešivčnik Novljan¹, Sabina Škrgat^{2

4}

Affiliations

¹ Department of Rheumatology, University Medical Centre Ljubljana, Ljubljana, Slovenia.
² Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
³ University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia.
⁴ Department of Pulmology, University Medical Centre Ljubljana, Ljubljana, Slovenia.

PMID: 33280004
DOI: 10.1093/rheumatology/keaa798

No abstract available

Publication types

Comment

MeSH terms

Asthma* / drug therapy
Churg-Strauss Syndrome* / chemically induced
Churg-Strauss Syndrome* / drug therapy
Eosinophils
Granulomatosis with Polyangiitis*
Humans
Interleukin-5

Substances

Interleukin-5